L
ADING

Articles

NHS Improvement Announces New Chief Executive
NHS Improvement Announces New Chief Executive
Jim Mackey will start to bring together expert teams to deliver all of NHS Improvement's.
Read more.
Reduction In Malaria Death Toll But Risk Remains
Reduction In Malaria Death Toll But Risk Remains
Malaria death rates have plunged by 60% since 2000.
Read more.
Swiss Researchers Explore Benefits of Mediterranean Diet
Swiss Researchers Explore Benefits of Mediterranean Diet
First study of its kind in Switzerland explores lifestyle choices and how these impact on health
Read more.
Ulcerative Colitis
Lipid Therapeutics Licenses Rights to its Novel Therapy for Ulcerative Colitis
Lipid Therapeutics today announced that it has entered into a licensing agreement with Nestl' Health Science
Read more.
Health Secretary Outlines Vision for use of Technology Across NHS
Health Secretary Outlines Vision for use of Technology Across NHS
Patients will be able to access and interact with their GP record online within 12 months.
Read more.
Apaziquone set for Phase Three Trial
Apaziquone set for Phase Three Trial
Spectrum Pharmaceuticals announces agreement with FDA on the Special Protocol Assessment (SPA)
Read more.
Accelerated Assessment for Ixazomib
Accelerated Assessment for Ixazomib
European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Read more.
Evidence Shows New Technique Spares More Breast Cancer Suffers� Nipples
Evidence Shows New Technique Spares More Breast Cancer Suffers’ Nipples
A new study published in the journal Plastic and Reconstructive Surgery proves that more breast cancer patients can qualify for
Read more.
Researchers Reap Rewards
Researchers Reap Rewards
Two top researchers into Alzheimer's disease receive the 2015 MetLife Foundation Awards for Medical Research
Read more.
Tech Mahindra to Supply NHS Hospital Tech
Tech Mahindra to Supply NHS Hospital Tech
Tech Mahindra announced a 10 year deal with Circle Health.
Read more.
CHMP Recommends Levemir� for Treatment of Diabetes of 1 Year Olds
CHMP Recommends Levemir’ for Treatment of Diabetes of 1 Year Olds
The Committee for Medicinal Products for Human Use has recommended Levemir' is offered to children as young as one year
Read more.